跳至主要内容
临床试验/EUCTR2006-003717-41-IT
EUCTR2006-003717-41-IT进行中(未招募)不适用

EVALUATE THE TOLERABILITY AND EFFICACY OF OMEGA 3 ON MOOD ANDMOTOR SYMPTOMS OF PATIENTS SUFFERING FROM PARKINSON DISEASE - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2007年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adult patients attending the clinical centre for Parkinson disease of Neuroscience Department of A. Gemelli Hospital, Catholic University of Sacred Heart, in Rome with:
  • - diagnosis of Parkinson disease
  • - antiparkinson therapy steady since at least 6 months
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • monogenic type of Parkinson disease (diagnosis genetically confirmed)
  • - liver insufficiency
  • - kidney insufficiency
  • - important coagulation failure and anticoagulant therapy
  • - valproate therapy
  • - presence of psychiatric disorders (psychotic disorders) severely interfering with the evaluation
  • - pregnancy

研究者

发起方
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

相似试验